TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06990737

Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Poor accrual”

The sponsor’s own words in the registry.

Life of this trial

202520262027Registered2025-05-16Planned start2025-06-25 (planned)Withdrawn (as of)2026-08-31

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
University of California, Davis
Sponsor type
University, hospital or other
Conditions
Cutaneous Squamous Cell Carcinoma of the Head and Neck; Clinically Node-Negative (cN0); High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
Interventions
Sentinel lymph node biopsy (SLNB); Lymphadenectomy; Adjuvant Definitive Therapy
Participants
0

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.